Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Science Translational Medicine|May 1, 2024
Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza diseaseZhaochen Luo, Hector A Miranda, Kaitlyn N Burke, et al.Cell|May 1, 2020
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and InfluenzaTimothy R Abbott, Girija Dhamdhere, Yanxia Liu, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
CGRP reception potentiates anxiety in an influenza A derived immune engramSarah K Monroe, Benjamin A Devlin, Ariana Vaida, et al.Science Advances|June 1, 2019
Control of antiviral innate immune response by protein geranylgeranylationShigao Yang, Alfred T Harding, Catherine Sweeney, et al.Cell Stem Cell|October 31, 2020
Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte DysfunctionHiroaki Katsura, Vishwaraj Sontake, Aleksandra Tata, et al.Acta Biomaterialia|November 20, 2025
Presentation of hemagglutinin on adjuvant-bearing self-assembling peptide nanofibers increases heterologous responses against influenzaEmily F Roe, Nicole L Votaw, Kat M Lazar, et al.Cell Genomics|December 5, 2022
Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virusBenjamin H Schott, Liuyang Wang, Xinyu Zhu, et al.Plos Pathogens|July 5, 2024
mRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNALorena C S Chaves, Nichole Orr-Burks, Daryll Vanover, et al.Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.Biorxiv : the Preprint Server for Biology|August 1, 2026
Elicitation of stem-directed antibodies in rhesus macaques by a conventional hemagglutinin immunogenShuqin Gu, Joel Finney, Kan Luo, et al.Pageof 11